Archive: Company News
Company News: BioNTech to Present at Cowen and Company’s 37th Annual Health Care Conference
BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that Sean Marett, COO of BioNTech, will be presenting at Cowen and Company’s 37th Annual Health Care Conference that is being held in Boston, MA from March 6 – 8, 2017. The presentation is scheduled for Tuesday, March 7 at 10:00AM Eastern Standard Time.
Company News: Standard reference ‘Infections of the musculoskeletal system’ is now available for free as an e-book
– As the publisher, Heraeus Medical is making the 2nd edition of the reference available for download
Heraeus Medical has financed and published the current 2nd edition of the standard reference ‘Infections of the musculoskeletal system’ and is making it available for free in the form of an e-book. Read more…
Company News: Results of Cervical Cancer Study Sponsored by ISA Pharmaceuticals to Be Presented at ASCO-SITC
— First data of phase I/II trial in HPV16-positive patients with late-stage cervical cancer
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company, today announced that results of a company-sponsored clinical Phase I/II trial in late-stage cervical cancer (ISA101-CervISA) will be presented at the inaugural ASCO-SITC congress on immuno-oncology (February 23-25, 2017, Orlando, FL, USA).
Company News: Multiplexed Analysis of ALK, ROS1, and RET Rearrangements in Lung Cancer Enabled by the MassARRAY® System
Agena Bioscience today announced a comparative study published in Scientific Reports highlighting the use of its mass spec-based platform for transcriptome analysis of ALK, ROS1, and RET gene fusions in lung cancer.